| Comparison of saliva and nasopharyngeal swab nucleic acid amplification testing for detection of SARS-CoV-2: a systematic review and meta-analysis G Butler-Laporte, A Lawandi, I Schiller, M Yao, N Dendukuri, ... JAMA internal medicine 181 (3), 353-360, 2021 | 343 | 2021 |
| Blood culture results before and after antimicrobial administration in patients with severe manifestations of sepsis: a diagnostic study MP Cheng, R Stenstrom, K Paquette, SN Stabler, M Akhter, AC Davidson, ... Annals of internal medicine 171 (8), 547-554, 2019 | 208 | 2019 |
| Association between caseload surge and COVID-19 survival in 558 US hospitals, March to August 2020 SS Kadri, J Sun, A Lawandi, JR Strich, LM Busch, M Keller, A Babiker, ... Annals of Internal Medicine 174 (9), 1240-1251, 2021 | 201 | 2021 |
| Adjunctive Daptomycin in the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Randomized, Controlled Trial MP Cheng, A Lawandi, G Butler-Laporte, S De l’Étoile-Morel, K Paquette, ... Clinical Infectious Diseases 72 (9), e196-e203, 2021 | 49 | 2021 |
| Comparison of saliva and nasopharyngeal swab nucleic acid amplification testing for detection of SARS-CoV-2: a systematic review and meta-analysis. JAMA Intern Med. 2021; 181 … G Butler-Laporte, A Lawandi, I Schiller, M Yao, N Dendukuri, ... Epub 2021/01/16. https://doi. org/10.1001/jamainternmed. 2020.8876 PMID …, 2020 | 34 | 2020 |
| On the Treatment of Pneumocystis jirovecii Pneumonia: Current Practice Based on Outdated Evidence EG McDonald, G Butler-Laporte, O Del Corpo, JM Hsu, A Lawandi, ... Open forum infectious diseases 8 (12), ofab545, 2021 | 29 | 2021 |
| Suspected severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) reinfections: incidence, predictors, and healthcare use among patients at 238 US healthcare facilities, 1 … A Lawandi, S Warner, J Sun, CY Demirkale, RL Danner, M Klompas, ... Clinical Infectious Diseases 74 (8), 1489-1492, 2022 | 28 | 2022 |
| IDSA guidance and ESCMID guidelines: complementary approaches toward a care standard for MDR Gram-negative infections A Lawandi, C Yek, SS Kadri Clinical Microbiology and Infection 28 (4), 465-469, 2022 | 26 | 2022 |
| Comparison of saliva and nasopharyngeal swab nucleic acid amplification testing for detection of SARS-CoV-2: a systematic review and meta-analysis. JAMA Intern Med 181: 353-360 G Butler-Laporte, A Lawandi, I Schiller, M Yao, N Dendukuri, ... | 18 | 2020 |
| Neither blood culture positivity nor time to positivity is associated with mortality among patients presenting with severe manifestations of sepsis: the FABLED cohort study K Paquette, D Sweet, R Stenstrom, SN Stabler, A Lawandi, M Akhter, ... Open Forum Infectious Diseases 8 (7), ofab321, 2021 | 17 | 2021 |
| Proton pump inhibitors versus histamine-2 receptor antagonists likely increase mortality in critical care: an updated meta-analysis TC Lee, MG Wilson, A Lawandi, EG McDonald The American Journal of Medicine 134 (3), e184-e188, 2021 | 15 | 2021 |
| Assessing clinician utilization of next-generation antibiotics against resistant Gram-negative infections in US hospitals: a retrospective cohort study JR Strich, A Mishuk, G Diao, A Lawandi, W Li, CY Demirkale, A Babiker, ... Annals of internal medicine 177 (5), 559-572, 2024 | 12 | 2024 |
| Real-world time to positivity of 2 widely used commercial blood culture systems in patients with severe manifestations of sepsis: an analysis of the FABLED study G Butler-Laporte, CP Yansouni, K Paquette, A Lawandi, SN Stabler, ... Open Forum Infectious Diseases 7 (9), ofaa371, 2020 | 11 | 2020 |
| Trends in empiric broad-spectrum antibiotic use for suspected community-onset sepsis in US hospitals C Rhee, T Chen, SS Kadri, A Lawandi, C Yek, M Walker, S Warner, ... JAMA Network Open 7 (6), e2418923-e2418923, 2024 | 10 | 2024 |
| Suspected SARS-CoV-2 reinfections: incidence, predictors, and healthcare use among patients at 238 US healthcare facilities, June 1, 2020-February 28, 2021 A Lawandi, S Warner, J Sun, CY Demirkale, RL Danner, M Klompas, ... Clin Infect Dis 74, 1489-92, 2021 | 10 | 2021 |
| Reliability of admission procalcitonin testing for capturing bacteremia across the sepsis spectrum: real-world utilization and performance characteristics, 65 US hospitals … A Lawandi, M Oshiro, S Warner, G Diao, JR Strich, A Babiker, C Rhee, ... Critical care medicine 51 (11), 1527-1537, 2023 | 9 | 2023 |
| Low-dose trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison … ZN Sohani, G Butler-Laporte, A Aw, S Belga, A Benedetti, A Carignan, ... BMJ open 12 (7), e053039, 2022 | 9 | 2022 |
| Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled … MP Cheng, A Lawandi, G Butler-Laporte, K Paquette, TC Lee Trials 19, 1-9, 2018 | 8 | 2018 |
| Rapid phenotypic testing for detection of carbapenemase-or extended-spectrum ß-lactamase-producing Enterobacterales directly from blood cultures: a systematic review and meta … O Del Corpo, J Senécal, JM Hsu, A Lawandi, TC Lee Clinical Microbiology and Infection 29 (12), 1516-1527, 2023 | 7 | 2023 |
| Antibody tests have higher sensitivity at≥ 15 days after symptom onset and 99% specificity for detecting SARS-CoV-2 A Lawandi, RL Danner Annals of internal medicine 173 (10), JC57, 2020 | 7 | 2020 |
